- Home
- PVLA vs AUDC Comparison
PVLA vs AUDC Comparison
Compare PVLA & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVLA
- AUDC
- Stock Information
- Founded
- PVLA 2015
- AUDC 1992
- Country
- PVLA United States
- AUDC Israel
- Employees
- PVLA N/A
- AUDC N/A
- Industry
- PVLA Biotechnology: Pharmaceutical Preparations
- AUDC Telecommunications Equipment
- Sector
- PVLA Health Care
- AUDC Utilities
- Exchange
- PVLA Nasdaq
- AUDC Nasdaq
- Market Cap
- PVLA 253.2M
- AUDC 279.1M
- IPO Year
- PVLA N/A
- AUDC 1999
- Fundamental
- Price
- PVLA $22.30
- AUDC $9.44
- Analyst Decision
- PVLA Strong Buy
- AUDC Buy
- Analyst Count
- PVLA 7
- AUDC 3
- Target Price
- PVLA $46.29
- AUDC $11.67
- AVG Volume (30 Days)
- PVLA 81.8K
- AUDC 49.1K
- Earning Date
- PVLA 08-15-2025
- AUDC 07-29-2025
- Dividend Yield
- PVLA N/A
- AUDC 1.90%
- EPS Growth
- PVLA N/A
- AUDC 57.57
- EPS
- PVLA N/A
- AUDC 0.56
- Revenue
- PVLA N/A
- AUDC $242,474,000.00
- Revenue This Year
- PVLA N/A
- AUDC $1.54
- Revenue Next Year
- PVLA N/A
- AUDC $1.41
- P/E Ratio
- PVLA N/A
- AUDC $16.84
- Revenue Growth
- PVLA N/A
- AUDC N/A
- 52 Week Low
- PVLA $11.17
- AUDC $7.70
- 52 Week High
- PVLA $29.27
- AUDC $12.72
- Technical
- Relative Strength Index (RSI)
- PVLA N/A
- AUDC 54.43
- Support Level
- PVLA N/A
- AUDC $9.06
- Resistance Level
- PVLA N/A
- AUDC $9.54
- Average True Range (ATR)
- PVLA 0.00
- AUDC 0.20
- MACD
- PVLA 0.00
- AUDC -0.00
- Stochastic Oscillator
- PVLA 0.00
- AUDC 67.02
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.